International Business Machines Corporation
—- Market cap
- $279.95B
- Debt
- —
- Cash
- −$13.59B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: IBM stock price vs HWM: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HWM's multiple
Needs HWM P/E.
Implied fair value · at IBM's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
INTERNATIONAL BUSINESS MACHINES CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
HOWMET AEROSPACE INC. · implied price per share
Bear
$28.59
Base
$34.63
Bull
$42.49
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Microsoft Corporation
IBM vs MSFT
Oracle Corporation
IBM vs ORCL
Cisco Systems, Inc.
IBM vs CSCO
Cognizant Technology Solutions Corporation
IBM vs CTSH
RTX Corp
IBM vs RTX
LOCKHEED MARTIN CORP
IBM vs LMT
NORTHROP GRUMMAN CORP /DE/
IBM vs NOC
BOEING CO
IBM vs BA
GENERAL DYNAMICS CORP
IBM vs GD
HUNTINGTON INGALLS INDUSTRIES, INC.
IBM vs HII
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe IBM's current discount to HWM is unwarranted and IBM can sustain its 7.6% revenue growth with 58.2% gross margin and 30.8% EBITDA margin, then IBM looks attractive because it trades at 26.5x P/E versus HWM's 76.1x and below its historical valuation band.
IBM's current price of $223.65 is far below the P/E-based implied price of $849.82, implying 280.0% upside on this framework. The gap is also well below HWM implied range of $855.42 to $981.03 and below IBM's historical band of $266.59 to $325.83, suggesting the market is valuing IBM at a substantial discount to the HWM multiple benchmark.
Supporting Metrics